Overview

Influenza Diagnostics Market is poised to value over USD 1.6 billion by 2027 end with a CAGR of over 7.6% during the forecast period 2020 to 2027. 

Rise in the incidences of influenza, growing research for influenza diagnostics, increasing insistence for an efficient diagnostic system are some of the key factors responsible for the growth of the market. As influenza is a highly contagious disease, highly populated areas are more prone to this disease as the transmission of the disease becomes easier in areas with high population density. Furthermore, the treatment and management of influenza is a challenging task in tropical areas where this disease occurs throughout the year. In addition, children, pregnant women, immunosuppressed patients suffering from appalling medical conditions and geriatric population are high risk individuals when it comes to influenza. 
Escalating geriatric population, rising number of initiatives undertaken by the government for countering influenza and rising prevalence of appalling diseases like cardiovascular diseases, diabetes are some other driving factors contributing to the influenza diagnostics market growth. Furthermore, rise in the high-risk population shall increased the demand for diagnostics, thereby boosting the market growth. As per the report provided by the CDC, over 80 labs confirmed that the district of Puerto Rico, Columbia and over 30 other states has recorded paediatric deaths. In 2016, over 4,500 influenza-related deaths were recorded in the United States. Influenza is easily treatable, but timely diagnosis and adequate treatment is key in eliminating the disease across the world, thereby increasing the importance of diagnostics and boosting the market growth substantially.

Influenza Diagnostics Market

Market Segmentation:

By Test Type
•    Traditional Diagnostic Tests

•    Molecular Diagnostic Tests

By End User
•    Hospitals
•    Point of Care Laboratories
•    Laboratories
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into test type, end user and region. The test type segment is fragmented into traditional diagnostic test and molecular diagnostic tests. The molecular diagnostic test segment is divided into reverse transcription polymerase chain reaction (RT-PCR), INNAT while the traditional diagnostic tests segment is further divided into rapid influenza diagnostic test (RIDT), DFA, viral culture, serological assays. The RIDT segment is predicted to hold the largest influenza diagnostics market share and this is mainly owing to its capability of det4cting influenza type B and A in specimens. This test is considered as a benchmark for influenza diagnostics as it can provide results within 30 minutes, thereby increasing its popularity among patients. On the other hand, the RT-PCR is expected to proliferate with a substantial growth rate during the forecast period. RT-CPR test can deliver results in 20 minutes or it may even take 2 hours, depending on the kind of case. These tests can detect both nonviable and viable influenza virus. Furthermore, the chances of obtaining false positive or negative results are very low in these tests, thereby making it more reliable than other forms of tests. However, the RT-PCR test is expensive when compared to other tests for diagnosing influenza which can impede the growth of this segment. 
The end user segment is fragmented into laboratories, point of care labs and hospitals. The hospital segment dominated the market, but it is the point of care diagnostic labs that are predicted to subjugate the market during the forecast period owing to the increased accuracy in the results provided by these laboratories as compared to hospitals. Furthermore, it is easy to use, and it does not require any medical expertise, except understanding the basic operations. The physician and the public are more reliant on these tests owing to their accuracy, thus boosting the growth of this segment.   

Regional Analysis:

The North America region is expected to lead the market owing to several initiatives undertaken by the government in creating awareness regarding the diagnosis and treatment of influenza. Additionally, technological advancements along with increased healthcare expenditure is predicted to boost the growth of the market in the region. However, the Asia Pacific region is anticipated to grow rapidly during the forecast period and this is due to a rise in the population density and increasing geriatric population in the region. 

Competitive Landscape:                            

The key market players associated are F. Hoffmann-La Roche Ag, Quidel Corporation, Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Hologic, Inc., Becton, Dickinson and Company, Danaher Corporation, Diasorin Sa, Meridian Bioscience, Luminex Corporation.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global influenza diagnostics market by test type, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions  

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics